SEARCH

SEARCH BY CITATION

References

  • Abulafia D. P., de Rivero Vaccari J. P., Lozano J. D., Lotocki G., Keane R. W. and Dietrich W. D. (2009) Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow Metab. 29, 534544.
  • Ago T., Liu T., Zhai P., Chen W., Li H., Molkentin J. D., Vatner S. F. and Sadoshima J. (2008) A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133, 978993.
  • Akashi-Takamura S. and Miyake K. (2008) TLR accessory molecules. Curr. Opin. Immunol. 20, 420425.
  • Allan S. M., Tyrrell P. J. and Rothwell N. J. (2005) Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629640.
  • Arimura K., Ago T., Kamouchi M., Nakamura K., Ishitsuka K., Kuroda J., Sugimori H., Ooboshi H., Sasaki T. and Kitazono T. (2012) PDGF receptor signaling in pericytes following ischemic brain injury. Curr. Neurovasc. Res. 9, 19.
  • Arslan F., Smeets M. B., O'Neill L. A. et al. (2010) Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 121, 8090.
  • Asahi M., Asahi K., Jung J. C., del Zoppo G. J., Fini M. E. and Lo E. H. (2000) Role for matrix metalloproteinase 9 after cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 16811689.
  • Barone F. C. and Feuerstein G. Z. (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819834.
  • Becker K. J. (2009) Sensitization and tolerization to brain antigens in stroke. Neuroscience 158, 10901097.
  • Becker K., Kindrick D., McCarron R., Hallenbeck J. and Winn R. (2003) Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury? Stroke 34, 18091815.
  • Boutin H., LeFeuvre R. A., Horai R., Asano M., Iwakura Y. and Rothwell N. J. (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 21, 55285534.
  • Brea D., Blanco M., Ramos-Cabrer P., Moldes O., Arias S., Pérez-Mato M., Leira R., Sobrino T. and Castillo J. (2011) Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J. Cereb. Blood Flow Metab. 31, 14241431.
  • Chakraborty S., Kaushik D. K., Gupta M. and Basu A. (2010) Inflammasome signaling at the heart of central nervous system pathology. J. Neurosci. Res. 88, 16151631.
  • Chen G. Y. and Nuñez G. (2010) Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826837.
  • Chen C. J., Kono H., Golenbock D., Reed G., Akira S. and Rock K. L. (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13, 851856.
  • Chen F., Liu Z., Wu W., Rozo C., Bowdridge S., Millman A., Van Rooijen N., Urban J. F. Jr, Wynn T. A. and Gause W. C. (2012) An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 18, 260266.
  • Chou J. L., Wu C. H., Tsai C. Y., Chang A. Y. and Chan S. H. (2011) Proteomic investigation of a neural substrate intimately related to brain death. Proteomics 11, 239248.
  • Clausen B. H., Lambertsen K. L., Babcock A. A., Holm T. H., Dagnaes-Hansen F. and Finsen B. (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflammation 5, 46.
  • Cohen J. A., Barkhof F., Comi G. et al. and TRANSFORMS Study Group. (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med.. 362, 402415.
  • Connolly E. S. Jr, Winfree C. J., Springer T. A., Naka Y., Liao H., Yan S. D., Stern D. M., Solomon R. A., Gutierrez-Ramos J. C. and Pinsky D. J. (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209216.
  • Cua D. J., Sherlock J., Chen Y. et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744748.
  • Dayon L., Turck N., Garcí-Berrocoso T., Walter N., Burkhard P. R., Vilalta A., Sahuquillo J., Montaner J. and Sanchez J. C. (2011) Brain extracellular fluid protein changes in acute stroke patients. J. Proteome Res. 10, 10431051.
  • Dev K. K., Mullershausen F., Mattes H., Kuhn R. R., Bilbe G., Hoyer D. and Mir A. (2008) Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol. Ther. 117, 7793.
  • Dirnagl U., Klehmet J., Braun J. S., Harms H., Meisel C., Ziemssen T., Prass K. and Meisel A. (2007) Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 38, 770773.
  • Eltzschig H. K. and Eckle T. (2011) Ischemia and reperfusion—from mechanism to translation. Nat. Med. 17, 13911401.
  • Famakin B. M., Mou Y., Ruetzler C. A., Bembry J., Maric D. and Hallenbeck J. M. (2011) Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia. Brain Res. 1388, 148156.
  • Farrar C. A., Keogh B., McCormack W., O'Shaughnessy A., Parker A., Reilly M. and Sacks S. H. (2012) Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J. 26, 799807.
  • Fossiez F., Djossou O., Chomarat P. et al. (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 25932603.
  • Fraser P. A. (2011) The role of radical generation in increasing cerebrovascular permeability. Free Radic. Biol. Med. 51, 967977.
  • Gertz K., Kronenberg G., Kälin R. E. et al. (2012) Essential role of interleukin-6 in post-stroke angiogenesis. Brain 135, 19641980.
  • Hallenbeck J. M. (2002) The many faces of tumor necrosis factor in stroke. Nat. Med. 8, 13631368.
  • Hasegawa Y., Suzuki H., Sozen T., Rolland W. and Zhang J. H. (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368374.
  • Hayakawa K., Qiu J. and Lo E. H. (2010) Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann. N. Y. Acad. Sci. 1207, 5057.
  • Hurn P. D., Subramanian S., Parker S. M., Afentoulis M. E., Kaler L. J., Vandenbark A. A. and Offner H. (2007) T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow Metab. 27, 17981805.
  • Hyakkoku K., Hamanaka J., Tsuruma K., Shimazawa M., Tanaka H., Uematsu S., Akira S., Inagaki N., Nagai H. and Hara H. (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171, 258267.
  • Iadecola C. (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5, 347360.
  • Iadecola C. and Anrather J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796808.
  • Ifergan I., Kébir H., Bernard M., Wosik K., Dodelet-Devillers A., Cayrol R., Arbour N. and Prat A. (2008) The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131, 785799.
  • Jander S., Karemer M., Schroeter M., Witte O. W. and Stoll G. (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15, 4251.
  • Jung J. E., Kim G. S. and Chan P. H. (2011) Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 42, 35743579.
  • Kamouchi M., Ago T. and Kitazono T. (2011) Brain pericytes: emerging concepts and functional roles in brain homeostasis. Cell. Mol. Neurobiol. 31, 175193.
  • Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B. and Prat A. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 11731175.
  • Kim J. B., Sig Choi J., Yu Y. M., Nam K., Piao C. S., Kim S. W., Lee M. H., Han P. L., Park J. S. and Lee J. K. (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26, 64136421.
  • Konoeda F., Shichita T., Yoshida H., Sugiyama Y., Muto G., Hasegawa E., Morita R., Suzuki N. and Yoshimura A. (2010) Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. Biochem. Biophys. Res. Commun. 402, 500506.
  • Kumai Y., Ooboshi H., Takada J., Kamouchi M., Kitazono T., Egashira K., Ibayashi S. and Iida M. (2004) Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats. J. Cereb. Blood Flow Metab. 24, 13591368.
  • Lai A. Y. and Todd K. G. (2006) Microglia in cerebral ischemia: molecular actions and interactions. Can. J. Physiol. Pharmacol. 84, 4959.
  • Lakhan S. E., Kirchgessner A. and Hofer M. (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.
  • Lambertsen K. L., Gregersen R., Meldgaard M., Clausen B. H., Heibøl E. K., Ladeby R., Knudsen J., Frandsen A., Owens T. and Finsen B. (2004) A role for interferon-gamma in focal cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 63, 942955.
  • Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T. and Veltkamp R. (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192199.
  • Liesz A., Sun L., Zhou W., Schwarting S., Mracsko E., Zorn M., Bauer H., Sommer C. and Veltkamp R. (2011a) FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia. PLoS ONE 6, e21312.
  • Liesz A., Zhou W., Mracskó É. et al. (2011b) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704720.
  • Liu T., Clark R. K., McDonnell P. C., Young P. R., White R. F., Barone F. C. and Feuerstein G. Z. (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25, 14811488.
  • Liu K., Mori S., Takahashi H. K. et al. (2007) Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. FASEB J. 21, 39043916.
  • Lo E. H. (2010) Degeneration and repair in central nervous system disease. Nat. Med. 16, 12051209.
  • Macrez R., Ali C., Toutirais O., Le Mauff B., Defer G., Dirnagl U. and Vivien D. (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 10, 471480.
  • Marsh B. J., Williams-Karnesky R. L. and Stenzel-Poore M. P. (2009) Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 10071020.
  • Martin B., Hirota K., Cua D. J., Stockinger B. and Veldhoen M. (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321330.
  • Martinon F., Burns K. and Tschopp J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta. Mol. Cell 10, 417426.
  • Meisel C. and Meisel A. (2011) Suppressing immunosuppression after stroke. N. Engl. J. Med. 365, 21342136.
  • Morancho A., Rosell A., Garcia-Bonilla L. and Montaner J. (2010) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann. N. Y. Acad. Sci. 1207, 123133.
  • Moskowitz M. A., Lo E. H. and Iadecola C. (2010) The science of stroke: mechanisms in search of treatments. Neuron 67, 181198.
  • Motomura Y., Kitamura H., Hijikata A. et al. (2011) The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4 T cells. Nat. Immunol. 12, 450459.
  • Offner H., Subramanian S., Parker S. M., Wang C., Afentoulis M. E., Lewis A., Vandenbark A. A. and Hurn P. D. (2006) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176, 65236531.
  • Okamura T., Fujio K., Shibuya M., Sumitomo S., Shoda H., Sakaguchi S. and Yamamoto K. (2009) CD4 + CD25-LAG3 +  regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl Acad. Sci. USA 106, 1397413979.
  • Ooboshi H., Ibayashi S., Shichita T. et al. (2006) Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111, 913919.
  • Patenaude A., Murthy M. R. and Mirault M. E. (2005) Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell. Mol. Life Sci. 62, 10631080.
  • Pfeilschifter W., Czech-Zechmeister B., Sujak M., Foerch C., Wichelhaus T. A. and Pfeilschifter J. (2011) Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice. Exp. Transl. Stroke Med. 3, 2.
  • Qiu J., Nishimura M., Wang Y., Sims J. R., Qiu S., Savitz S. I., Salomone S. and Moskowitz M. A. (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J. Cereb. Blood Flow Metab. 28, 927938.
  • Rashidian J., Rousseaux M. W., Venderova K. et al. (2009) Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J. Neurosci. 29, 1249712505.
  • Rathinum V. A., Vanaja S. K. and Fitzgerald K. A. (2012) Regulation of inflammasome signaling. Nat. Immunol. 13, 333342.
  • Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B. and Sallusto F. (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514523.
  • Ren X., Akiyoshi K., Dziennis S., Vandenbark A. A., Herson P. S., Hurn P. D. and Offner H. (2011) Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J. Neurosci. 31, 85568563.
  • Rivest S. (2009) Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429439.
  • Schroeter M., Jander S., Witte O. W. and Stoll G. (1994) Local immune responses in the rat middle cerebral artery occlusion. J. Neuroimmunol. 55, 195203.
  • Shichita T., Sugiyama Y., Ooboshi H. et al. (2009) Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946950.
  • Shichita T., Hasegawa E., Kimura A. et al. (2012) Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 18, 911918.
  • Soriano S. G., Coxon A., Wang Y. F., Frosch M. P., Lipton S. A., Hickey P. R. and Mayadas T. N. (1999) Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 30, 134139.
  • Stetler R. A., Gao Y., Zhang L. et al. (2012) Phosphorylation of HSP27 by protein kinase D is essential for mediating neuroprotection against ischemic neuronal injury. J. Neurosci. 32, 26672682.
  • Stewart C. R., Stuart L. M., Wilkinson K. et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155161.
  • Strecker J. K., Minnerup J., Gess B., Ringelstein E. B., Schäbitz W. R. and Schilling M. (2011) Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1b and G-CSF after transient focal ischemia in mice. PLoS ONE 6, e25863.
  • Subramanian S., Zhang B., Kosaka Y., Burrows G. G., Grafe M. R., Vandenbark A. A., Hurn P. D. and Offner H. (2009) Recombinant T cell receptor ligand treats experimental stroke. Stroke 40, 25392545.
  • Sutton C. E., Lalor S. J., Sweeney C. M., Brereton C. F., Lavelle E. C. and Mills K. H. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331341.
  • Takano T., Oberheim N., Cotrina M. L. and Nedergaard M. (2009) Astrocytes and ischemic injury. Stroke 40, S8S12.
  • Tang S. C., Arumugam T. V., Xu X. et al. (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl Acad. Sci. USA 104, 1379813803.
  • Terao S., Yilmaz G., Stokes K. Y., Russell J., Ishikawa M., Kawase T. and Granger D. N. (2008) Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 39, 25602570.
  • Terao Y., Ohta H., Oda A., Nakagaito Y., Kiyota Y. and Shintani Y. (2009) Macrophage inflammatory protein-3alpha plays a key role in the inflammatory cascade in rat focal cerebral ischemia. Neurosci. Res. 64, 7582.
  • Vogelgesang A., Grunwald U., Langner S., Jack R., Bröker B. M., Kessler C. and Dressel A. (2008) Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39, 237241.
  • Wei Y., Yemisci M., Kim H. H. et al. (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 69, 119129.
  • Whitesell L., Bagatell R. and Falsey R. (2003) The stress response: implications for the clinical development of hsp90 inhibitors. Curr. Cancer Drug Targets 3, 349358.
  • Wong C. H., Jenne C. N., Leger C. and Kubes P. (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101105.
  • Wood Z. A., Schröder E., Robin Harris J. and Poole L. B. (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 3240.
  • Xiong X., Barreto G. E., Xu L., Ouyang Y. B., Xie X. and Giffard R. G. (2011) Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 42, 20262032.
  • Yadav A., Kalita A., Dhillon S. and Banerjee K. (2005) JAK/STAT3 pathway is involved in survival of neurons in response to insulin like growth factor and negatively regulated by suppressor of cytokine signal-3. J. Biol. Chem. 280, 3183031840.
  • Yamashita T., Sawamoto K., Suzuki S., Suzuki N., Adachi K., Kawase T., Mihara M., Ohsugi Y., Abe K. and Okano H. (2005) Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J. Neurochem. 94, 459468.
  • Yanai H., Ban T., Wang Z. et al. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462, 99103.
  • Yang Q. W., Lu F. L., Zhou Y., Wang L., Zhong Q., Lin S., Xiang J., Li J. C., Fang C. Q. and Wang J. Z. (2011) HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J. Cereb. Blood Flow Metab. 31, 593605.
  • Yilmaz G., Arumugam T. V., Stokes K. Y. and Granger D. N. (2006) Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113, 21052112.
  • Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K. and Hauser C. J. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104107.
  • Zhang J., Takahashi H. K., Liu K. et al. (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42, 14201428.
  • Zheng K., Kim J. Y., Ma H., Lee J. E. and Yenari M. A. (2008) Anti-inflammatory effects of the 70 kDa heat shock protein in experimental stroke. J. Cereb. Blood Flow Metab. 28, 5363.
  • del Zoppo G. J. (2006) Stroke and neurovascular protection. N. Engl. J. Med. 354, 553555.